The Morning Dispatch: What Comes Next for Build Back Better?

Happy Friday! An early Christmas present from your friends at The Dispatch: An edit button for the comments section!

Quick Hits: Today’s Top Stories

  • The Centers for Disease Control on Thursday recommended Americans seeking COVID-19 vaccines and boosters choose the Moderna or Pfizer shots rather than Johnson & Johnson’s, as the latter has been linked to a rare blood clotting issue that has led to between nine and 11 confirmed deaths. Approximately 17 million doses of the J&J vaccine have been administered in the United States, compared with a combined 470 million doses of the two-dose Moderna and Pfizer vaccines.

  • The Senate voted unanimously Thursday to pass the Uyghur Forced Labor Prevention Act, sending the legislation—which would prohibit all imports from China’s Xinjiang region unless it can be proven they weren’t made with forced labor—to President Joe Biden’s desk. The White House said this week Biden will sign the bill into law.

  • The Food and Drug Administration said Thursday it will lift a regulation requiring abortion pills “be dispensed only in healthcare settings,” allowing providers to prescribe the pills—used up to 10 weeks’ gestation—via telemedicine and send them to women in the mail. Nearly two dozen states, however, have preemptively banned the practice.

This content is available exclusively to Dispatch members
Try a membership for full access to every newsletter and all of The Dispatch. Support quality, fact-based journalism.
Already a paid member? Sign In
Comments (0)
Join The Dispatch to participate in the comments.

There are currently no responses to this article.
Be the first to respond.